1218 Taisun: Abnormal Test Results Detected in Product Inspection

Release Date: July 17, 115 Statement Date: July 16, 115 Statement Time: 18:40:54 Company Code: 1218 Company Name: Taisun Subject: Company Receives Abnormal Test Report for Submitted Samples Today Applicable Clause: Clause 51 Factual Date: July 16, 115

Details: 1. Factual Date: 07/16/115 2. Company Name: Taisun Enterprise Co., Ltd. 3. Relationship with Company (Enter 'Company' or 'Subsidiary'): Company 4. Cross-shareholding Ratio: Not applicable 5. Reason for Occurrence: The company recently submitted its oil products for third-party testing and received the test report today. The benzo(a)pyrene level in the 1.5L Unsaturated Blended Oil was 2.3 ppb, and in the 500mL Premium European Vegetable Oil Blend it was 2.1 ppb. Both test results failed to meet Taiwan's regulatory standards, and the company has already reported this to the Changhua County Health Bureau. Additionally, today the Food and Drug Administration announced that oil products manufactured by Zhonglian Oils on April 1 were not reported and are not listed in the official registry. The competent authority will trace the distribution of this batch and verify its withdrawal status. Since July 9, the company has, in accordance with regulatory requirements, instructed all distributors to conduct a preventive withdrawal of all oil products and related items manufactured by Zhonglian Oils between April and June. The two items with abnormal test results and products made from oil produced by Zhonglian Oils on April 1 were already included in the list of items subject to preventive withdrawal. 6. Response Measures: As described in item 5 above. 7. Other Matters to be Disclosed (If the entity involved in the event or resolution is a publicly listed company or above, this material information also qualifies under Article 7, Paragraph 9 of the Enforcement Rules of the Securities and Exchange Act as an event having a significant impact on shareholders' rights or securities prices): None.